ArticlePregnancy (Hoboken, N.J.)2025
Outcomes in prenatally suspected focal placenta accreta spectrum.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Introduction: Morbidity of placenta accreta spectrum (PAS) increases with increasing severity of placental attachment. PAS with only a focal area of invasion or focal PAS based on magnetic resonance imaging (MRI) has been defined in a previous study as the greatest dimension of involvement of 25 mm or less. The objective of this study was to describe maternal and neonatal outcomes in patients with prenatally suspected focal PAS as defined by MRI imaging. Methods: This is a retrospective cohort study evaluating prenatally suspected focal PAS between 2020 and 2024. Focal PAS was defined based on MRI. Delivery and neonatal outcomes were described for the entire cohort and these outcomes were then compared between patients who delivered at <37 weeks (preterm) or at ≥37 weeks (term). A neonatal composite of cord pH < 7, cord base excess <-12, APGARs ≤3, continuous positive airway pressure/ventilator support, hypoxic ischemic encephalopathy, birthweight <3rd percentile, neonatal intensive care unit admission (NICU), and hypoglycemia was compared. Results: Of 40 cases of prenatally suspected focal PAS, 21 (52%) cases delivered preterm and 19 (48%) delivered at term. Six (15%) met International Federation of Gynecology and Obstetrics (FIGO) clinical criteria for PAS. Hysterectomy was performed in 3 (8%) cases. Pathology was negative in 33 (85%) patients, not sent in 1 patient, and positive for PAS in 6. The neonatal composite occurred in 11 (28%) neonates. Median APGARs at 1 min were 6 (6-8), no neonate had a pH < 7, and median birthweight was 2905 g (2721-3108 g). Ten (25%) infants were admitted to the NICU. Patients delivered preterm were more likely to have a placenta previa (76% vs. 42%, Conclusion: Delivery and neonatal outcomes were favorable in cases of prenatally suspected focal PAS with low overall hysterectomy rates. Term delivery did not impact maternal outcomes, improved neonatal outcomes, and can be considered in an otherwise uncomplicated patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.